These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23325368)

  • 21. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
    Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
    Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT(1B/1D) receptors.
    Bingham S; Davey PT; Sammons M; Raval P; Overend P; Parsons AA
    Exp Neurol; 2001 Jan; 167(1):65-73. PubMed ID: 11161594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Kayser V; Aubel B; Hamon M; Bourgoin S
    Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine.
    Rainero I; Valfrè W; Savi L; Gentile S; Pinessi L; Gianotti L; Arvat E; Ghigo E; Del Rizzo P; Calvelli P; Limone P
    J Endocrinol Invest; 2001 May; 24(5):310-4. PubMed ID: 11407649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased sensitivity of 5-HT1D receptors in chronic tension-type headache.
    Rainero I; Valfrè W; Savi L; Ferrero M; Del Rizzo P; Limone P; Isaia GC; Gianotti L; Pollo A; Verde R; Benedetti F; Pinessi L
    Headache; 2002 Sep; 42(8):709-14. PubMed ID: 12390633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors.
    Facchinetti F; Nappi RE; Sances G; Fioroni L; Nappi G; Genazzani AR
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):211-4. PubMed ID: 8137520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols.
    Longmore J; Hargreaves RJ; Boulanger CM; Brown MJ; Desta B; Ferro A; Schofield WN; Taylor AA; Hill RG
    Funct Neurol; 1997; 12(1):3-9. PubMed ID: 9127118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Sumatriptan Treatment During a Migraine Attack and Central 5-HT1B Receptor Binding.
    Deen M; Hougaard A; Hansen HD; Schain M; Dyssegaard A; Knudsen GM; Ashina M
    JAMA Neurol; 2019 Jul; 76(7):834-840. PubMed ID: 31135819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C; Eriksson A; Tellefors P; Ross SB; Stenfors C; Malmberg A
    Eur J Pharmacol; 2004 Sep; 499(1-2):67-75. PubMed ID: 15363952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT(1B/1D) serotonin receptor agonist attenuates nitroglycerin-evoked nitric oxide synthase expression in trigeminal pathway.
    Suwattanasophon C; Phansuwan-Pujito P; Srikiatkhachorn A
    Cephalalgia; 2003 Oct; 23(8):825-32. PubMed ID: 14510930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
    Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine treatment and the prolactin response to sumatriptan.
    Wing YK; Clifford EM; Sheehan BD; Campling GM; Hockney RA; Cowen PJ
    Psychopharmacology (Berl); 1996 Apr; 124(4):377-9. PubMed ID: 8739554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
    Whale R; Bhagwagar Z; Cowen PJ
    Psychopharmacology (Berl); 1999 Jul; 145(2):223-6. PubMed ID: 10463324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?
    McCann GP; Cahill H; Knipe S; Muir DF; MacIntyre PD; Hillis WS
    Clin Sci (Lond); 2000 Jun; 98(6):643-8. PubMed ID: 10814600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological challenge with a serotonin 1D agonist in alcohol dependence.
    Vythilingum B; Hugo CJ; Maritz JS; Pienaar W; Stein DJ
    BMC Psychiatry; 2005 Aug; 5():31. PubMed ID: 16120224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of peptides corresponding to extracellular domains of serotonin 1B/1D receptors and melanocortin 3 and 4 receptors on hormonal regulation of adenylate cyclase in rat brain.
    Shpakova EA; Derkach KV; Shpakov AO
    Bull Exp Biol Med; 2014 Mar; 156(5):658-62. PubMed ID: 24770752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
    Blumenfeld A; Gennings C; Cady R
    Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype.
    Centurión D; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
    Br J Pharmacol; 2001 Mar; 132(5):991-8. PubMed ID: 11226129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control.
    Fanciullacci M; Sicuteri R; Alessandri M; Geppetti P
    Clin Pharmacol Ther; 1995 Mar; 57(3):349-55. PubMed ID: 7697953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
    Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
    Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.